Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
LX-101 by Innostellar Biotherapeutics for Retinal Degeneration: Likelihood of Approval
LX-101 is under clinical development by Innostellar Biotherapeutics and currently in Phase II for Retinal Degeneration. According to GlobalData, Phase...